Nicola Potter

12PUBLICATIONS
79CO-AUTHORS
Medical infection agents (incl. prions)Medical virologyMedical mycologyPredictive and prognostic markersTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 01, 2026
Prognostic Impact of FLT3-ITD Microclones in AML: An EHA AML-Specialized Working Group Study.

|Jun 04, 2026
ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.

|Sep 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Nigel Russell, Jad Othman, Oliver Cumming

|Aug 06, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML.

Jad Othman, Nicola Potter, Sylvie D Freeman

|Sep 24, 2024
Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia.

Sun Loo, Nicola Potter, Adam Ivey

|Sep 16, 2024
Pitfalls in Diagnosis: JMML versus KMT2A Rearranged Juvenile AML.

Liesbeth Vanheeswijck, Sanjay Tewari, Robin Dowse

Pageof 2

Frequent Collaborators

9 joint publications

Jad Othman

6 joint publications

Richard Dillon

5 joint publications

Sylvie D Freeman

4 joint publications

Ing Soo Tiong